preCigma
AI-Native Financial Modeling and Analytics Platform for Biotech Portfolio Management
Portfolio Valuation
Asset valuation (NPV, rNPV, IRR etc.), sensitivity and optimization analysis.
Scenario Planning
Decision-ready scenario models that stress-tests adoption, timing, and competitive/technology shifts for priority innovation bets. Converts each scenario into clear investment, timing, and resource-allocation choices for leadership reviews
Predictive P&L and Revenue Forcasting
Analyzes historical sales data, market trends, competitive landscape, regulatory timelines, and macroeconomic signals to generate continuously updated commercial forecasts.
Market Potential Modeling
AI-driven simulation of clinical utility and health-economic value for pipeline assets — before heavy R&D investment.
→
→
FAQs
What is Precigma?
We provide AI-driven document analysis.
How does it work?
Our platform extracts and analyzes clinical data quickly.
Who can use the platform?
Any company needing insights from clinical documents.
Is it user-friendly?
Yes, it's designed for easy navigation.
What support is available?
We offer 24/7 customer support.
Can I customize analysis tools?
Absolutely, our tools are highly customizable.
Contact
Get in touch with us for inquiries.